Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting ...Middle East

-- BV Market Projected to Reach $1.0 Billion in the U.S. by 2033 -- -- BV Affects 21 Million U.S. Women; As many as 50% Experience Recurrent BV Within Six Months of Treatment -- SAN DIEGO, June 11, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM) today...

Read More Details
Finally We wish PressBee provided you with enough information of ( Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting )

Also on site :

• Air India plane crashes at India’s Ahmedabad airport, source says
• Why Steve Sarkisian and oddsmakers are exactly right about the new era of the SEC
• Air India plane crashes shortly after take-off in Ahmedabad